Search company, investor...

ExcelleRx Inc.


Acq - Fin | Acquired

About ExcelleRx Inc.

Provider of technology-enabled medication consultation, management, and distribution services to the hospice, chronic pain, and transplant markets. Through the Web, the company provides realtime access to its proprietary evidence-based relational database of patient-specific medication information in which users can follow similar patients, the therapies they used, and comparative outcomes. Medication recommendations are based on clinical experience, case reporting, patient endpoints and outcomes data, and current physician prescribing trends.

Headquarters Location

1601 Cherry Street Suite 1700

Philadelphia, Pennsylvania, 19102,

United States


Missing: ExcelleRx Inc.'s Product Demo & Case Studies

Promote your product offering to tech buyers.

Reach 1000s of buyers who use CB Insights to identify vendors, demo products, and make purchasing decisions.

Missing: ExcelleRx Inc.'s Product & Differentiators

Don’t let your products get skipped. Buyers use our vendor rankings to shortlist companies and drive requests for proposals (RFPs).

ExcelleRx Inc. Frequently Asked Questions (FAQ)

  • Where is ExcelleRx Inc.'s headquarters?

    ExcelleRx Inc.'s headquarters is located at 1601 Cherry Street, Philadelphia.

  • What is ExcelleRx Inc.'s latest funding round?

    ExcelleRx Inc.'s latest funding round is Acq - Fin.

  • Who are the investors of ExcelleRx Inc.?

    Investors of ExcelleRx Inc. include Consonance Capital.

Discover the right solution for your team

The CB Insights tech market intelligence platform analyzes millions of data points on vendors, products, partnerships, and patents to help your team find their next technology solution.

Request a demo

CBI websites generally use certain cookies to enable better interactions with our sites and services. Use of these cookies, which may be stored on your device, permits us to improve and customize your experience. You can read more about your cookie choices at our privacy policy here. By continuing to use this site you are consenting to these choices.